The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

Condition:   The Neoadjuvant Therapy Interventions:   Drug: Ribocyclib, fulvestrant, triptorelin;   Drug: Doxorubicin, cyclophosphamide, paclitaxel Sponsor:   Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials